MARKET

AYTU

AYTU

Aytu BioScience
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.9130
+0.0873
+10.57%
Closed 17:51 12/13 EST
OPEN
0.8300
PREV CLOSE
0.8257
HIGH
0.9200
LOW
0.7990
VOLUME
227.80K
TURNOVER
--
52 WEEK HIGH
2.610
52 WEEK LOW
0.6500
MARKET CAP
18.93M
P/E (TTM)
-0.3527
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of AYTU and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

AYTU News

  • Aytu Bioscience (AYTU) Investor Presentation - Slideshow
  • Seeking Alpha - Article.15h ago
  • INVESTOR ALERT: Monteverde & Associates PC Is Investigating The Following Transaction
  • ACCESSWIRE.1d ago
  • CERC: Expansion in Rare and Orphan Diseases with Acquisition of Aevi Genomic Medicine…
  • Zacks Small Cap Research.2d ago
  • SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of the Following Mergers
  • GlobeNewswire.3d ago

More

Industry

Biotechnology & Medical Research
+1.07%
Pharmaceuticals & Medical Research
-0.32%

Hot Stocks

Name
Price
%Change

About AYTU

Aytu BioScience, Inc. is a commercial-stage healthcare company focused on acquiring, developing and commercializing products in the field of urology. The Company focuses on hypogonadism, prostate cancer, urinary tract infections and male infertility. The Company markets ProstaScint (capromab pendetide), a radio imaging agent indicated to detect the prostate specific membrane antigen (PSMA) in the assessment and staging of prostate cancer. The Company's pipeline includes MiOXSYS, an in vitro diagnostic device. MiOXSYS system is a point-of-care semen analysis system, used for diagnosis and management of male infertility. The Company holds the United States rights to Natesto (testosterone), a formulation of testosterone delivered through a nasal gel. Natesto is used for the treatment of hypogonadism (low testosterone) in men. The Company, through its wholly-owned subsidiary Nuelle, Inc., is focused on women’s sexual wellbeing and intimacy.
More

Webull offers Aytu Bioscience Inc (AYTU) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.